Higashimori et al. demonstrated that the NLRP3 inflammasome regulated the damage, as well as caspase-1 activation and IL-1β processing, that played a crucial role in the enteropathy induced by non-steroidal anti-inflammatory agents21. Here, NLRP3 is linked to Abnormal intestine morphology.